Analysts expect Janux Therapeutics to announce earnings of ($0.26) per share and revenue of $19.0750 million for the quarter. Janux Therapeutics (NASDAQ:JANX – Get Free Report) last released its earnings results on Thursday, May 7th. On average, analysts expect Janux Therapeutics to post $-2 EPS for the current fiscal year and $-3 EPS for the next fiscal year. Get Janux Therapeutics alerts:Janux Therapeutics Trading Down 0.3%Shares of Janux Therapeutics stock opened at $14.96 on Thursday. Recommended StoriesReceive News & Ratings for Janux Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Janux Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.